HMOX1 and Myocardial fibrosis: Another study demonstrated that pharmacological modulation of the heme oxygenase-1 pathway offers protection against intermittent hypoxia-induced cardiac dysfunction and myocardial fibrosis by inhibiting cell apoptosis and mitochondrial fission (Han et al., 2018).